wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49561302-1489F184-CFD7-415D-BCB2-0138FC802474
Q49561302-1489F184-CFD7-415D-BCB2-0138FC802474
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49561302-1489F184-CFD7-415D-BCB2-0138FC802474
S2k Guidelines - Cutaneous Lymphomas Update 2016 - Part 2: Treatment and Follow-up (ICD10 C82 - C86).
P2860
Q49561302-1489F184-CFD7-415D-BCB2-0138FC802474
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49561302-1489F184-CFD7-415D-BCB2-0138FC802474
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
43976fbe7ab14a19498436b153bf134ff3c570aa
P2860
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients.